Aerosol Products

Oral Spray Device Testing

Particle size, spray pattern, emitted dose, and use-condition testing for oral spray devices.

Controlled actuation, oral-interface fixtures, particle sizing, plume imaging, dose collection, and assay support for development and regulatory documentation.

ISO 17025USP <601>ISO 13320FDA nasal / inhalation sprayReviewed 2026-05-17
Request a quoteSubmit a sample

Testing oral spray devices

Oral spray device testing connects the pump, actuator, nozzle, formulation, dose volume, and user interface to measurable spray performance. USP <601>, ISO 13320, and FDA nasal / inhalation spray guidance concepts help frame droplet size, spray geometry, emitted dose, and use-condition collection when no single oral-spray standard governs the product. Testing supports decisions when:

  1. PSD testing compares oral spray formulations, pumps, and nozzles using ISO 13320 laser diffraction or aerodynamic sizing when respirable aerosol is a concern.
  2. Spray pattern and plume geometry document actuator, nozzle, or viscosity changes for FDA comparability and product-quality documentation.
  3. Dose uniformity and emitted dose studies quantify actuation-to-actuation output, priming state, and orientation effects under USP <601> concepts.
  4. Breathing simulation evaluates mouthpiece geometry, inhalation timing, and oral fixture collection using USP <601> and FDA use-condition framing.
  5. Stability pulls track PSD, plume, emitted dose, clogging, and residue effects after ICH Q1A storage or product-specific aging conditions.

Use oral spray testing when droplet size, plume direction, dose consistency, or user coordination could change delivered material. A defined protocol locks the actuation sequence, oral-interface geometry, collection endpoint, assay plan, and acceptance logic before samples arrive.

Core test menu for oral spray devices

Oral spray programs usually combine particle sizing, plume imaging, dose collection, and breathing simulation. Select the set by device geometry, formulation state, comparator strategy, and documentation need.

Test method options

MethodStrengthsTradeoffAligned with
Oral spray PSD and droplet-size screen
  • Laser diffraction or aerodynamic sizing compares formulations, pumps, nozzles, and spray counts under ISO 13320 or USP <601> concepts.
  • Rapid screens identify respirable fractions, droplet drift, and formulation effects before committing to larger dose or fixture studies.
Optical or aerodynamic size data do not prove delivered active mass; pair with emitted-dose recovery when dose is the decision.
ISO 13320USP <601>
Spray pattern, plume geometry, and high-speed imaging
  • Laser sheet and high-speed imaging quantify plume angle, width, footprint, breakup, and pulsing for FDA change-control comparisons.
  • Controlled distance, orientation, and trigger timing isolate nozzle or formulation effects from operator technique.
Imaging endpoints describe spray behavior, not recovered material; combine with PSD or dose data for delivery claims.
FDA nasal / inhalation sprayASTM E2832
Emitted dose and dose-uniformity series
  • Defined actuation sequences measure emitted dose, priming effects, orientation, and spray-count variability under USP <601> concepts.
  • Assay recovery controls connect collected material to active, tracer, or surrogate concentration for FDA documentation.
Collection adapters and assay readiness drive setup time when device geometry or formulation matrix is new.
USP <601>FDA nasal / inhalation spray
Breathing and oral-interface simulation
  • Programmable breathing profiles test mouthpiece geometry, inhalation timing, and collection efficiency with USP <601> dose logic.
  • Oral fixtures and mannequins support exposure, deposition, and use-condition comparisons without claiming clinical replacement.
Results depend on profile assumptions and fixture geometry; those assumptions must be declared before interpretation.
USP <601>ISO 20072
Stability-linked spray performance pulls
  • Conditioned pulls track PSD, plume, emitted dose, residue, and clogging across ICH Q1A storage or product-specific aging.
  • Trend plots connect formulation or package changes to measurable output shifts before shelf-life or comparator decisions.
Study duration follows storage and pull timing; analytical scheduling should be planned before conditioning begins.
ICH Q1A

Setup configurations

Every oral spray study is configured around the device geometry, actuation behavior, formulation state, and endpoint. The same product can need different fixtures for PSD, plume imaging, dose recovery, or breathing simulation. Study planning locks the spray count, priming state, orientation, distance, collection media, environmental conditions, and replicate structure before testing starts.

Device interfaces

Actuator holders, mouthpiece adapters, oral-cavity fixtures, collection targets, filters, impingers, and custom holders matched to pump, bottle, or nozzle geometry.

Flow & actuation profiles

Manual, semi-automated, or automated actuation with force, stroke, timing, spray distance, device orientation, breath profile, and shot interval documented per run.

Sample numbers

Device count, spray count, priming state, beginning or end-of-use pulls, and analytical replicates sized to variability, assay sensitivity, and decision risk.

Media & handling

Filters, fixtures, extraction solvents, collection surfaces, storage conditions, cleaning steps, and chain of custody set for active, tracer, or surrogate recovery.

Environmental controls

Temperature, RH, fill level, conditioning history, residue state, and aging condition logged when formulation viscosity or actuator behavior may shift.

Quality frame for oral spray testing

Oral spray studies run inside a documented quality system anchored to the accreditation and method references used most often for aerosol performance, particle sizing, and spray documentation.

  • ISO 17025AccreditedLaboratory competence, calibration traceability, method control, and uncertainty contributors.
  • USP <601>AccreditedAerosol and spray performance tests used for dose and particle endpoints.
  • ISO 13320AlignedLaser diffraction particle-size analysis for droplet-spectrum studies.
  • FDA nasal / inhalation sprayAlignedCMC expectations adapted to spray performance and documentation questions.

Key data outputs & reporting

Oral spray programs receive endpoint-specific datasets that connect device setup to measured spray performance: PSD curves, plume images, emitted-dose statistics, recovery data, breathing-profile collection results, and QA/QC controls. Reports are formatted for development review, troubleshooting, comparability, or stability trend interpretation. Extended deliverables add the appendices needed when a program includes storage pulls, comparator devices, or use-condition simulations.

Primary outputs

  • Particle or droplet-size distribution tables, Dv10 / Dv50 / Dv90, aerodynamic fractions, and concentration trends by device condition.
  • Spray pattern area, plume angle, plume width, high-speed image observations, and actuator-to-actuator comparisons.
  • Emitted dose, dose uniformity, active or tracer recovery, deposition mass, and collection efficiency by spray count or fixture location.
  • Breathing-profile and oral-interface notes, including fixture geometry, profile assumptions, sampling locations, and interpretation limits.

Deliverables

#FormatContents
01PDF reportProtocol summary, setup, controls, deviations, results, and interpretation limits.
02CSV / XLSX datasetsPSD tables, dose statistics, plume metrics, and recovery data.
03Images / videoSpray pattern files, plume frames, overlays, and high-speed video exports.
Extended deliverables · multi-arm comparability · stability · predicate studies
  • Comparability appendix — Side-by-side PSD, plume, and emitted-dose summaries for reference products or device-change review.
  • Stability trend pack — Timepoint tables and figures showing particle size, plume, dose, residue, and clogging changes.
  • Use-condition notes — Breathing profile assumptions, fixture rationale, collection efficiency notes, and exposure interpretation limits.

QA / QC & data integrity

Each oral spray study carries a QA/QC plan matched to the selected endpoints, assay, and documentation need. Controls run beside collection so particle, plume, dose, and recovery data remain traceable from sample receipt through final report. Method deviations, invalid runs, and uncertainty contributors are documented rather than hidden in summary tables.

Blanks, device-off backgrounds, comparator devices, reference aerosols, or replicate actuations defined by endpoint and collection train.

Flow meters, balances, impactor stages, imaging scales, timers, actuation fixtures, and environmental sensors checked or calibrated before use.

Assay controls for HPLC, GC/MS, FTIR, ELISA, or ddPCR, including calibration standards and recovery checks when required.

Chain of custody for devices, collected filters, fixtures, extracts, image files, instrument exports, and analyst observations.

Predefined acceptance criteria, replicate rules, carryover checks, deviation handling, and outlier logic included in the protocol.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
QualityDocumented study records
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

Quick answers to questions oral spray development and regulatory teams ask when scoping a study: which endpoints to combine, how devices and actuations are counted, when breathing simulation matters, and what documentation is delivered. Most oral spray programs need at least one product-specific fixture, actuation, or assay decision that is best resolved during study planning.

Q.Which oral spray test should I start with?
A.Start with the decision. PSD answers droplet-size behavior, plume imaging answers nozzle and spray formation, dose testing answers output consistency, and breathing simulation answers use-condition collection. Many programs combine two or more endpoints.
Q.Can ARE Labs test dose consistency?
A.Yes. Emitted-dose and dose-uniformity studies can be configured around defined actuation force, spray count, orientation, priming state, collection media, and analytical endpoint. The study does not replace clinical dosing or approval work.
Q.How many devices or sprays are needed?
A.Device count, spray count, and replicate count depend on the number of configurations, priming states, endpoints, assay sensitivity, and whether the work is exploratory or documentation-focused. We define counts during protocol development.
Q.When is breathing simulation useful?
A.Use breathing simulation when mouthpiece geometry, inhalation timing, breath-hold assumptions, or oral-cavity collection could change recovered material. The protocol declares the profile and fixture assumptions before testing.
Q.What data will I receive?
A.Deliverables can include PSD curves, plume images, spray pattern metrics, high-speed video, emitted-dose tables, recovery data, raw files, deviations, QA/QC records, and a written report.
Q.Does this cover full regulatory approval?
A.No. Testing can support product development, method justification, comparator studies, troubleshooting, and regulatory documentation. Clinical studies, labeling review, toxicology programs, and full submission management are outside this page's scope.

Standards & guidance

Oral spray programs at ARE Labs are aligned to the compendial, consensus, and regulatory references that best fit the product question. Some oral spray products have no single governing performance standard, so the study plan states which references apply, which controls are adapted, and where the protocol is fit for purpose. Accredited scopes are reported as accredited; other references are followed as aligned where applicable.

Inhalation & Drug Delivery - Accredited

USP <601>

Aerosol and spray performance concepts for dose, APSD, actuation, and collection setupView standard ->Aerosol & Particle Measurement - Aligned

ISO 13320

Laser diffraction particle-size analysis for spray droplet distributionsView standard ->QA & Regulatory - Aligned

FDA nasal / inhalation spray

CMC guidance concepts for droplet size, spray pattern, plume geometry, and dose controlsView standard ->Aerosol & Particle Measurement - Aligned

ASTM E2832

Imaging-system context for transient spray behavior and plume velocimetryView standard ->Inhalation & Drug Delivery - Aligned

ISO 20072

Aerosol drug delivery device dose-delivery concepts used for oral spray collection plansView standard ->QA & Regulatory - Aligned

ICH Q1A

Storage conditions, pull timing, and trend interpretation for stability-linked spray testingView standard ->

Related testing services

Test

Particle Size Distribution (PSD) Testing

Pairs with oral spray development to compare droplet spectra, respirable fractions, and particle-size drift across formulations, pumps, or storage pulls.Read more ->Test

Spray Pattern & Plume Geometry

Documents nozzle and formulation effects on plume angle, spray width, footprint, and transient spray behavior for comparator or troubleshooting studies.Read more ->Test

Dose Uniformity & Emitted Dose

Measures actuation-to-actuation output, priming state, orientation effects, and recovered active or tracer for metered oral spray devices.Read more ->Test

Breathing Simulation Testing

Adds inhalation profiles, oral fixtures, mouthpiece adapters, and use-condition collection when timing or geometry changes delivered material.Read more ->